Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ANGPT1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ANGPT1 is a concept in neurodegeneration research. Key relationships include: activates, co discussed, associated with. Associated with ALS, Als, Arthritis. Connected to 85 entities in the SciDEX knowledge graph.
| Name | ANGPT1 |
| Related Diseases | vascular barrier function, Vascular Permeability, Vascular Barrier Function |
| Related Pathways | Angiogenesis-Related Pathway, PI3K/AKT Pathway |
Knowledge base pages for this entity
graph TD
ANGPT1["ANGPT1"]
ANGPT1 -->|"expressed in"| Pericyte_Derived_Extracellular["Pericyte-Derived Extracellular Vesicles"]
ANGPT1 -->|"regulates"| Vascular_Permeability["Vascular Permeability"]
ANGPT1 -->|"activates"| PI3K_AKT_Pathway["PI3K/AKT Pathway"]
ANGPT1 -->|"regulates"| Intestinal_Barrier_Function["Intestinal Barrier Function"]
ANGPT1 -->|"downregulates"| Inflammatory_Cytokines["Inflammatory Cytokines"]
ANGPT1 -->|"activates"| Als["Als"]
ANGPT1 -->|"activates"| Cancer["Cancer"]
ANGPT1 -->|"activates"| Ms["Ms"]
ANGPT1 -->|"activates"| Tumor["Tumor"]
ANGPT1 -->|"activates"| Arthritis["Arthritis"]
h_35f04e1b["h-35f04e1b"] -->|"targets"| ANGPT1
BMP2["BMP2"] -->|"activates"| ANGPT1
VEGF["VEGF"] -->|"activates"| ANGPT1
FGF2["FGF2"] -->|"activates"| ANGPT1
CD8["CD8"] -->|"activates"| ANGPT1
VEGFB["VEGFB"] -->|"activates"| ANGPT1
RUNX2["RUNX2"] -->|"activates"| ANGPT1
PDGFRB["PDGFRB"] -->|"activates"| ANGPT1
GENES["GENES"] -->|"activates"| ANGPT1
PI3K["PI3K"] -->|"activates"| ANGPT1| Target | Relation | Type | Str |
|---|---|---|---|
| Pericyte-Derived Extracellular Vesicles | expressed_in | cell_type | 0.95 |
| Vascular Barrier Function | associated_with | process | 0.95 |
| vascular barrier function | promotes | phenotype | 0.95 |
| Pericyte-Derived Extracellular Vesicles | component_of | compound | 0.92 |
| Vascular Permeability | regulates | phenotype | 0.90 |
| Vascular Barrier Function | contributes_to | process | 0.90 |
| Vascular Barrier Function | activates | phenotype | 0.90 |
| Angiogenesis-Related Pathway | involved_in | pathway | 0.90 |
| PI3K/AKT Pathway | activates | pathway | 0.85 |
| Pericyte Recruitment | regulates | process | 0.85 |
| Pericyte Recruitment | mediates | process | 0.85 |
| Intestinal Barrier Function | protects_against | phenotype | 0.85 |
| vascular endothelial cell proliferation | promotes | process | 0.85 |
| Angiogenesis | promotes | process | 0.85 |
| Intestinal Barrier Function | regulates | phenotype | 0.80 |
| Intestinal Barrier Function | associated_with | phenotype | 0.80 |
| Pericyte Recruitment | promotes | process | 0.80 |
| Sepsis | treats | disease | 0.80 |
| Inflammatory Cytokines | downregulates | biomarker | 0.75 |
| Sepsis | associated_with | disease | 0.70 |
| Arthritis | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Sepsis | interacts_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Ischemia | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Alzheimer | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Diabetes | inhibits | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| PDGFRB | activates | gene | 0.60 |
| VEGFB | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Pericyte-derived Extracellular Vesicles | component_of | structure | 0.90 |
| Pericyte-derived Extracellular Vesicles | associated_with | cell_type | 0.90 |
| Pericyte-Derived Extracellular Vesicles | transports | cell_type | 0.90 |
| h-35f04e1b | targets_gene | hypothesis | 0.90 |
| Pericyte-Derived Extracellular Vesicles | associated_with | cell_type | 0.85 |
| STING | upregulates | protein | 0.85 |
| h-35f04e1b | targets | hypothesis | 0.80 |
| BMP2 | activates | gene | 0.60 |
| VEGF | activates | gene | 0.60 |
| FGF2 | activates | gene | 0.60 |
| CD8 | activates | gene | 0.60 |
| PDGFRB | associated_with | gene | 0.60 |
| VEGFB | activates | gene | 0.60 |
| PDGFRB | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| STING | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| BCL2L1 | associated_with | gene | 0.60 |
| MAP2K1 | associated_with | gene | 0.60 |
| AKT | associated_with | entity | 0.60 |
| GJA1 | associated_with | gene | 0.60 |
| VCAM1 | associated_with | gene | 0.60 |
| CD44 | associated_with | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| PIK3R1 | inhibits | gene | 0.60 |
| AHR | activates | gene | 0.60 |
| NOTCH3 | activates | gene | 0.60 |
| CLDN5 | inhibits | gene | 0.60 |
| PPAR | expressed_in | gene | 0.60 |
| VEGF | expressed_in | gene | 0.60 |
| TAU | causes | gene | 0.60 |
| HDAC2 | activates | gene | 0.60 |
| UCHL1 | activates | gene | 0.60 |
| RUNX2 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| PERICYTE | interacts_with | gene | 0.60 |
| CYTOKINES | interacts_with | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| CCL2 | associated_with | gene | 0.60 |
| HDAC | activates | gene | 0.60 |
| DEMENTIA | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| AREG | associated_with | gene | 0.60 |
| MAPK | associated_with | gene | 0.60 |
| YAP | activates | gene | 0.60 |
| HIF-1Α | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| WNT | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.605
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||